心力衰竭患者整合植入式装置研究进展

林 梅, 周丽 姝*
怒江傈僳族自治州人民医院心血管内科

摘要


心力衰竭是一组复杂临床综合征，药物治疗是慢性心力衰竭（尤其是射血分数降低型心力衰竭，HFrEF）的基石，GDMT（指南指导的药物治疗）已成为标准治疗的核心，但尽管GDMT广泛应用，全球范围内心力衰竭仍呈现高发病率和高死亡率的特点。因此，器械治疗逐渐成为重要的治疗选择，本文对心力衰竭的器械治疗原理及相关进展进行综述。

关键词


心力衰竭；心衰器械治疗；临床

全文:

PDF


参考


[1]张抒扬等.中国心力衰竭诊断和治疗指南2024[J].中华心血管病杂志，2024；52（3）期：235-275

[2]McDonagh, T.A., et al., 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal, 2023; 44(37): 3627-3639.

[3]Lam, Carolyn S.P.,et al,Recent successes in heart failure treatment Lam[J], Nature Medicine, 2023;29(10): 2424-2437.

[4]Paul W. Armstrong, M.D., et al.,Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction[J].The new england journal o f medicine,2020;382 (20), 1883-1893.

[5]Yuhui Zhang,et al.,Contemporary Epidemiology, Management, and Outcomes of Patients Hospitalized for Heart Failure in China[J].2017;23 (12), 868-875.

[6]Mullens, W., et al., Integration of implantable device therapy in patients with heart failure. A clinical consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC)[J]. Eur J Heart Fail, 2024;26(2): .483-501.

[7]Mascolo, A., et al., Current and future therapeutic perspective in chronic heart failure[J]. Pharmacological research,2022;175: 106035-106035.

[8]Naoki Taniguchi, M., et al., Heart Failure in Atrial Fibrillation[J]. Circ J., 2020. 84(8): 1212-1217.

[9]Ariyaratnam, J.P., et al., Heart failure with preserved ejection fraction: An alternative paradigm to explain the clinical implications of atrial fibrillation[J]. Heart rhythm O2, 2021. 2(6): 771-783.

[10]House, A.A., et al., Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference[J]. Kidney international, 2019. 95(6): 1304-1317.

[11]Naranjo, M., et al., Effects of Pulmonary Hypertension and Right Ventricular Function in Short and Long-Term Kidney Function[J]. Current cardiology reviews, 2019. 15(1): 3-11.

[12]宿燕岗等.植入型心律转复除颤器临床应用中国专家共识（2021）[J].中华心律失常学杂志，2021；25（4）：1282-1285

[13]Lambiase, P.D., et al., Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry. Eur Heart J, 2014. 35(25): 1657-65.

[14]张俊蒙等.心力衰竭再同步化治疗新理念：希浦系统起搏心脏再同步化治疗[J].中华心力衰竭和心肌病杂志，2019；3（3）：159-162

[15]李佳霖等.心脏再同步化治疗方法应用现状与进展[J].心血管病学进展，2023.44（12）：1065-1068.

[16]Vijayaraman, P., et al., His-Optimized Cardiac Resynchronization Therapy to Maximize Electrical Resynchronization[J]. Circulation: Arrhythmia and Electrophysiology, 2019. 12(2):e006934.

[17]Shan, P., et al., Direct His-Bundle Pacing Improved Left Ventricular Function and Remodelling in a Biventricular Pacing Nonresponder[J]. Canadian Journal of Cardiology, 2016. 32(12): 1577.e1-1577.e4.

[18]何姗姗等.心脏收缩力调节器治疗慢性心力衰竭的进展[J].国际心血管病杂志，2023.50（5）：269-273.

[19]卢群等.心脏收缩力调节器用于心力衰竭的机制和临床研究[J].中国介入心脏病学杂志，2024.32（8）：457-462.

[20]葛均波等.经导管二尖瓣缘对缘修复术的中国专家共识[J].中华心血管病杂志，2022.50（9）：853-863.

[21]谢春梅等.经导管三尖瓣缘对缘修复术的应用现状[J].中国介入心脏病学杂志，2024.32（1）：45-50.

[22]赖宇星等.心力衰竭器械治疗的研究进展.心血管病学进展[J]，2023.44（8）：718-723.

[23]赵双雷等.植入式左心室辅助装置在我国的应用与发展.中国医刊，2023.58（12）：1282-1285.


Refbacks

  • 当前没有refback。